Latest Breaking News On - Nicolaus company inc - Page 3 : comparemela.com

Acumen Announces Pricing of Upsized $130 Million Public Offering

CHARLOTTESVILLE, Va. and CARMEL, Ind., July 18, 2023 Acumen Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta.

United statesSan franciscoAlex braunJessica laubNicolaus company incBroadridge financial solutionsExchange commissionProspectus departmentAcumen pharmaceuticals incBofa securitiesTryon streetIsland avenueOne montgomery streetAcumen pharmaceuticalsPrivate securities litigation reform actAnnual report

Acumen Pharmaceuticals (ABOS) Prices Upsized 16 77M Share Offering at $7 75/sh

Acumen Pharmaceuticals (ABOS) Prices Upsized 16 77M Share Offering at $7 75/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoExchange commissionBroadridge financial solutionsAcumen pharmaceuticals incProspectus departmentNicolaus company incAcumen pharmaceuticalsBofa securitiesTryon streetIsland avenueOne montgomery street

Pieris Pharma Cuts Around 70% Workforce; Plans Strategic Options

Pieris Pharma Cuts Around 70% Workforce; Plans Strategic Options
nasdaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nasdaq.com Daily Mail and Mail on Sunday newspapers.

United kingdomStephen yoderPieris pharmaceuticals incMore such health newsNasdaq incNicolaus company inc

Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock

Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJessica laubAlex braunExchange commissionAcumen pharmaceuticals incProspectus departmentBroadridge financial solutionsNicolaus company incAcumen pharmaceuticalsBofa securitiesTryon streetIsland avenueOne montgomery streetPrivate securities litigation reform actAnnual report

Pieris Pharmaceuticals : Provides Strategic Update and Announces Restructuring

Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring BOSTON,MA, July 18, 2023 - Pieris Pharmaceuticals, Inc. , a clinical-stage biotechnology company.

United statesStephen yoderPieris pharmaceuticals provides strategicPieris pharmaceuticalsSecurities exchangeNicolaus company incExchange commissionPieris pharmaceuticals incCompany quarterly reports on formPieris pharmaceuticals provides strategic updateLooking statementsSecurities actSecurities exchange actAnnual reportQuarterly reports